Zdrowie i gospodarka · 31/01/2024
FDA Corrects Guidance on Monoclonal Antibody Products for SARS-CoV-2
The FDA is correcting a notice regarding the availability of a final guidance for industry on developing monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization, which was published with an incorrect docket number.